Pipetting Samples


See all our relevant publications below. 


Chappell KJ, Mordant FL, Li Z, Wijesundara DK, et al. 2021. First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2.. The Lancet. 

Watterson D, Wijesundara DK, Modhiran N, et al. 2021. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & Translational Immunology. 10(4)


Henry MN, MacDonald MA, Orellana CA, Gray PP, Gillard M, Baker K, Nielsen LK, Marcellin E, Mahler S, Martinez VS. 2020. Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production. Biotechnology and Bioengineering. 117(4)

Playford EG, Munro T, Mahler SM, et al. 2020. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. The Lancet Infectious Diseases. 4(20)

Sun B, Gillard M, Wu Y, Wu P, Xu ZP, Gu W. 2020. Bisphosphonate Stabilized Calcium Phosphate Nanoparticles for Effective Delivery of Plasmid DNA to Macrophages. ACS Applied Bio Material. 3(2)


Alfaleh MA, Arora N, Yeh M, de Bakker CJ, et al. 2019. Canine CD117-Specific Antibodies with Diverse Binding Properties Isolated from a Phage Display Library Using Cell-Based Biopanning. Antibodies. 8(1)

Findeisen M, Allen TL, Henstridge DC, et al.. 2019. Treatment of type 2 diabetes with the designer cytokine IC7Fc. Nature. 574 

Greenall SA, McKenzie M, Seminova E, et al.. 2019. Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma. Neuro-Oncology. 21(8)

Harkness L, Chen X, Gillard M, Gray PP, Davies AM. 2019. Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential. PLoS ONE. 14(3)

Islam J, Riley BT, Fercher C, Jones ML, Buckle AM, Howard CB, Cox RP, Bell TDM, Mahler S, Corrie SR. 2019. Wavelength-Dependent Fluorescent Immunosensors via Incorporation of Polarity Indicators near the Binding Interface of Antibody Fragments. Analytical Chemistry. 91(12)

Jones ML. 2019. Use of bacteriophage for discovery of therapeutically relevant antibodies against infectious diseases. Microbiology Australia. 40(1)

Lee MD, Tong WY, Nebl T, Pearce LA, Pham TM, Golbaz-Hagh A, Puttick S, Rose S, Adams TE, Williams CC. 2019. Dual Site-Specific Labeling of an Antibody Fragment through Sortase A and π-Clamp Conjugation. Bioconjugate Chemistry. 30(10)

Modhiran N, Gandhi NS, Wimmer N, Cheung S, Stacey K, Young PR, Ferro V, Watterson D. 2019. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545. Antiviral Research. 168

Raftery LJ, Howard CB, Grewal YS, et al. 2019. Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing. Lab on a Chip. 19

Sabir AJ, Adams TE, O'Rourke D, Devlin JM, Noormohammadi AH. 2019. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity. Veterinary Microbiology. 228

Vaz PK, Hartley CA, Lee SY, et al. 2019. Koala and Wombat Gammaherpesviruses Encode the First Known Viral NTPDase Homologs and Are Phylogenetically Divergent from All Known Gammaherpesviruses. Journal of Virology. 93(6)

Walton KL, Chen JL, Arnold Q, Kelly E, La M, Lu L, Lovrecz G, Hagg A, Colgan TD, et al.. 2019. Activin A–Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice. Endocrinology. 160(10)

Wang H, Kjer-Nielsen L, Shi M, et al. 2019. IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection. Science Immunology 4(41) 


Fontaine FR, Goodall S, Prokop JW, et al. 2018. Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach. mAbs. 10(4) 

Staudacher AH, Li Y, Liapis V, Cheng Hou JJ, Chin D, Dolezal O, Adams TE, van Berkel PH, Brown MP. 2018. APOMAB Antibody–Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo. Large Molecule Therapeutics. 18(2)

Wong KY, Baron R, Seldon TA, Jones ML, Rice AM, Munster DJ. 2018. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell–Mediated CD4 T Cell Responses. The Journal of Immunology. 200(10)